- Home
- Publications
- Publication Search
- Publication Details
Title
Interchangeability, immunogenicity and biosimilars
Authors
Keywords
-
Journal
NATURE BIOTECHNOLOGY
Volume 30, Issue 12, Pages 1186-1190
Publisher
Springer Nature
Online
2012-12-08
DOI
10.1038/nbt.2438
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The safety of switching between therapeutic proteins
- (2012) Hans C Ebbers et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Safety, immunogenicity and efficacy of subcutaneous biosimilar epoetin-α (HX575) in non-dialysis patients with renal anemia: a multi-center, randomized, double-blind study
- (2011) Marianne Haag-Weber et al. CLINICAL NEPHROLOGY
- Biosimilar recombinant human erythropoietin induces the production of neutralizing antibodies
- (2011) Kearkiat Praditpornsilpa et al. KIDNEY INTERNATIONAL
- Acceptable changes in quality attributes of glycosylated biopharmaceuticals
- (2011) Martin Schiestl et al. NATURE BIOTECHNOLOGY
- Tungsten-Induced Denaturation and Aggregation of Epoetin Alfa During Primary Packaging as a Cause of Immunogenicity
- (2011) Andreas Seidl et al. PHARMACEUTICAL RESEARCH
- Generic and therapeutic substitutions in the UK: are they a good thing?
- (2010) Martin G. Duerden et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Generic substitution: a need for clarification
- (2010) Gregory M. Peterson BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Biosimilars: controversies as illustrated by rhGH
- (2010) Paul J. Declerck et al. CURRENT MEDICAL RESEARCH AND OPINION
- Post-translational modifications of protein biopharmaceuticals
- (2010) Gary Walsh DRUG DISCOVERY TODAY
- Risk Management Plans: are they a tool for improving drug safety?
- (2010) Serena Frau et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Biosimilar agents in oncology/haematology: from approval to practice
- (2010) Dietger Niederwieser et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Dosing strategies for conversion of haemodialysis patients from short-acting erythropoiesis stimulating agents to once-monthly C.E.R.A.: experience from the MIRACEL study
- (2010) F. Dellanna et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Biosimilars and Regulatory Authorities
- (2010) Paola Minghetti et al. NEPHRON CLINICAL PRACTICE
- Quality of Original and Biosimilar Epoetin Products
- (2010) Vera Brinks et al. PHARMACEUTICAL RESEARCH
- Development of a new G-CSF product based on biosimilarity assessment
- (2009) P. Gascon et al. ANNALS OF ONCOLOGY
- Potential concerns about generic substitution: bioequivalence versus therapeutic equivalence of different amlodipine salt forms
- (2009) Peter A. Meredith CURRENT MEDICAL RESEARCH AND OPINION
- Biosimilars – Science, status, and strategic perspective
- (2009) Georg-Burkhard Kresse EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Tungsten-induced protein aggregation: Solution behavior
- (2009) Yijia Jiang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- A Peptide-Based Erythropoietin-Receptor Agonist for Pure Red-Cell Aplasia
- (2009) Iain C. Macdougall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council
- (2008) A. Covic et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now